Can PSA nadir predict prognosis in men receiving hormonal therapy for prostate cancer after primary treatment failure?
Fleshner
Neil
N
N Fleshner is an Associate Professor at the University of Toronto, and the Chief of Urology at the University Health Network, Toronto, ON, Canada.